Clinical Trial Update: Citicoline as Neuroprotector in Neonates Exposed to Hypoxia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating citicoline as a neuroprotector in neonates exposed to hypoxia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Hypoxia

Drugs mentioned

• Citicoline (CDP-choline)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Neonatal Hypoxia | Phase 3 | Status: RECRUITING